3722 related articles for article (PubMed ID: 7081141)
1. Misonidazole enhancement of the action of BCNU and melphalan against human melanoma xenografts.
Clutterbuck RD; Millar JL; McElwain TJ
Am J Clin Oncol; 1982 Feb; 5(1):73-8. PubMed ID: 7081141
[TBL] [Abstract][Full Text] [Related]
2. Effect of tumor size on S-2-(3-aminopropylamino)ethylphosphorothioic acid and misonidazole alteration of tumor response to cyclophosphamide.
Milas L; Ito H; Hunter N
Cancer Res; 1983 Jul; 43(7):3050-6. PubMed ID: 6303574
[TBL] [Abstract][Full Text] [Related]
3. Effects of various oxygenation conditions on the enhancement by Fluosol-DA of melphalan antitumor activity.
Teicher BA; Crawford JM; Holden SA; Cathcart KN
Cancer Res; 1987 Oct; 47(19):5036-41. PubMed ID: 3113727
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitizing effect of misonidazole in fractionated gamma-ray treatment of a human malignant melanoma grown in athymic nude mice.
Rofstad EK; Brustad T
Br J Radiol; 1979 May; 52(617):393-7. PubMed ID: 444837
[TBL] [Abstract][Full Text] [Related]
5. Synergistic interactions between cyclophosphamide or melphalan and VP-16 in a human rhabdomyosarcoma xenograft.
Lilley ER; Rosenberg MC; Elion GB; Colvin OM; Bigner DD; Friedman HS
Cancer Res; 1990 Jan; 50(2):284-7. PubMed ID: 2295068
[TBL] [Abstract][Full Text] [Related]
6. Hyperthermia-induced enhancement of melphalan activity against a melphalan-resistant human rhabdomyosarcoma xenograft.
Laskowitz DT; Elion GB; Dewhirst MW; Griffith OW; Savina PM; Blum MR; Prescott DM; Bigner DD; Friedman HS
Radiat Res; 1992 Feb; 129(2):218-23. PubMed ID: 1734453
[TBL] [Abstract][Full Text] [Related]
7. Effect of five antineoplastic agents on tumor xenografts with different growth rates.
Mattern J; Wayss K; Volm M
J Natl Cancer Inst; 1984 Jun; 72(6):1335-9. PubMed ID: 6587154
[TBL] [Abstract][Full Text] [Related]
8. Treatment of five subcutaneous human glioma tumor lines in athymic mice with carmustine, procarbazine, and mithramycin.
Schold SC; Bigner DD
Cancer Treat Rep; 1983 Sep; 67(9):811-9. PubMed ID: 6224556
[TBL] [Abstract][Full Text] [Related]
9. Prediction of in vivo tumor response to chemotherapeutic agents by the in vitro sister chromatid exchange assay.
Tofilon PJ; Basic I; Milas L
Cancer Res; 1985 May; 45(5):2025-30. PubMed ID: 4039220
[TBL] [Abstract][Full Text] [Related]
10. Enhanced cytotoxicity of antineoplastic agents following prolonged exposure to misonidazole.
Roizin-Towle LA; Hall EJ
Br J Cancer; 1981 Aug; 44(2):201-7. PubMed ID: 6168277
[TBL] [Abstract][Full Text] [Related]
11. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
Wong KH; Wallen CA; Wheeler KT
Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1043-50. PubMed ID: 2140824
[TBL] [Abstract][Full Text] [Related]
12. Radioresistance of human tumor xenografts: possible mechanisms.
Lehnert S; Guichard M
NCI Monogr; 1988; (6):205-9. PubMed ID: 3352766
[TBL] [Abstract][Full Text] [Related]
13. [Intensification of cytostatic action by radiosensitizers--a review of the present status of chemosensitization].
Moldenhauer H; Rose H; Saul G; Wolf G; Kehrberg G
Radiobiol Radiother (Berl); 1984; 25(2):289-95. PubMed ID: 6234615
[No Abstract] [Full Text] [Related]
14. Thermochemotherapy with cis-platinum, CCNU, BCNU, chlorambucil and melphalan on murine marrow and two tumours: therapeutic gain for melphalan only.
Honess DJ; Bleehen NM
Br J Radiol; 1985 Jan; 58(685):63-72. PubMed ID: 4063642
[TBL] [Abstract][Full Text] [Related]
15. Enhanced anti-tumour activity of carmustine (BCNU) with tumour necrosis factor in vitro and in vivo.
Jones AL; Millar JL; Millar BC; Powell B; Selby P; Winkley A; Lakhani S; Gore ME; McElwain TJ
Br J Cancer; 1990 Nov; 62(5):776-80. PubMed ID: 2245169
[TBL] [Abstract][Full Text] [Related]
16. Radioprotection combined with hypoxic sensitization during radiotherapy of a solid murine tumor.
Mendiondo OA; Grigsby PW; Beach JL
Radiology; 1983 Jul; 148(1):291-3. PubMed ID: 6304811
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic potentiation of nitrosoureas using chlorpromazine and caffeine in the treatment of murine tumors.
Rose WC; Trader MW; Dykes DJ; Laster WR; Schabel FM
Cancer Treat Rep; 1978 Dec; 62(12):2085-93. PubMed ID: 751716
[TBL] [Abstract][Full Text] [Related]
18. Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
Mulcahy RT; Siemann DW; Sutherland RM
Br J Cancer; 1982 Jun; 45(6):835-42. PubMed ID: 6212075
[TBL] [Abstract][Full Text] [Related]
19. 2-Nitroimidazole potentiation of nitrosourea induced cytotoxicity in subcutaneous implants of rat 9L brain tumor cells.
Wong KH; Wallen CA; Wheeler KT
J Neurooncol; 1991 Aug; 11(1):17-25. PubMed ID: 1833513
[TBL] [Abstract][Full Text] [Related]
20. [The effect of human lymphoblastoid interferon (HLBI) on the growth of 2 human malignant melanoma xenografts in nude mice].
Hashizume S
Gan To Kagaku Ryoho; 1984 Jun; 11(6):1296-302. PubMed ID: 6732256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
